SCHEMBL4844374

SCHEMBL4844374

COc1ccc2c(c1)C(=CC(=O)c1ccc(OC(=O)c3ccccc3)cc1)NC(C)(C)C2

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.45
ALDH1A1 P00352 4/20 0.45
CYP1A2 P05177 3/20 0.45
CYP2D6 P10635 3/20 0.45
CYP2C9 P11712 3/20 0.45
CYP2C19 P33261 3/20 0.45
LMNA P02545 2/20 0.45
CYP3A4 P08684 2/20 0.45
NPC1 O15118 1/20 0.45
HTT P42858 2/20 0.43
KMT2A Q03164 5/20 0.42
KDM4E B2RXH2 1/20 0.41
PTPN1 P18031 2/20 0.40
MEN1 O00255 3/20 0.39
NPSR1 Q6W5P4 1/20 0.39
HPGD P15428 3/20 0.39
GAA P10253 2/20 0.39
PKM P14618 1/20 0.38
MAPK1 P28482 1/20 0.38
CASP1 P29466 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4844364 1.00 MAPT (0.45) MAPTALDH1A1CYP1A2CYP2D6CYP2C9
SCHEMBL4846814 0.93 MAPT (0.48) MAPTALDH1A1CYP1A2CYP2D6CYP2C9
SCHEMBL4846826 0.93 MAPT (0.48) MAPTALDH1A1CYP1A2CYP2D6CYP2C9
SCHEMBL4837739 0.89 LMNA (0.44) MAPTALDH1A1CYP1A2CYP2D6CYP2C9
SCHEMBL4837747 0.89 LMNA (0.44) MAPTALDH1A1CYP1A2CYP2D6CYP2C9
SCHEMBL4842624 0.89 ALDH1A1 (0.49) MAPTALDH1A1CYP1A2CYP2D6CYP2C9
SCHEMBL4842612 0.89 ALDH1A1 (0.49) MAPTALDH1A1CYP1A2CYP2D6CYP2C9
SCHEMBL4840894 0.88 LMNA (0.45) MAPTALDH1A1CYP1A2CYP2D6CYP2C9
SCHEMBL4840881 0.88 LMNA (0.45) MAPTALDH1A1CYP1A2CYP2D6CYP2C9
SCHEMBL4840822 0.86 NPC1 (0.49) MAPTALDH1A1CYP1A2CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050222138-A1 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2005-10-06 US claimed
US-7378428-B2 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2008-05-27 US disclosed
US-20050222138-A1 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2005-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050222138-A1 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient PARK7, MMP8, CDK7 MAPT 646/4885ALDH1A1 2636/4885CYP1A2 2248/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.